AnorMED, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic drugs for the treatment of hematology, human immunodeficiency virus (HIV), and oncology. Its lead drug product candidate include MOZOBIL, which is under phase III clinical trial is used for cancer patients undergoing stem cell transplantation; and AMD070, which is under phase Ib/IIa trial is used as a HIV entry inhibitor.

Affymetrix, Inc. was an American company that manufactured DNA microarrays; it was based in Santa Clara, California, United States. The company was acquired by Thermo Fisher Scientific in March 2016. The company was founded by Stephen Fodor in 1992. It began as a unit in Affymax N.V. in 1991 by Fodor's group, which had in the late 1980s developed methods for fabricating DNA microarrays, called "GeneChip" according to the Affymetrix trademark, using semiconductor manufacturing techniques. The company's first product, an HIV genotyping GeneChip, was introduced in 1994 and the company went public in 1996. As a result of its pioneering work and the ensuing popularity of microarray products, Affymetrix derived significant benefit from its patent portfolio in this area.

Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA.

Nymirum, Inc. manufactures pharmaceutical drugs. It develops drugs to treat a variety of medical conditions that are caused by or are associated with excessive inflammation, including various forms of arthritis, obesity and type 2 diabetes mellitus. The company was founded by Andrew C. Stelzer, Hashim M. Al-Hashimi, Joshua P. Fairbank, and Michael E. Pape in 2009 and is headquartered in Ann Arbor, MI.

Henan Ruida Pharmaceutical Technology Co., Ltd., established on 2014-11-06, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;Information system integration service;Big data service;internet data service;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Healthy food(prepackaged)Sales;Food import and export;Specialty Chemicals Sales(Free of Hazardous Chemicals);Instrument sales;Disinfectant sales(Free of Hazardous Chemicals);Business Management Consulting;marketing planning;market survey(Does not include foreign investigations);Health Consulting Services(Does not include medical services);Digital Content Production Services(Does not include publishing);Computer and communication equipment rental;Retailing of computer software, hardware and auxiliary equipment;Cosmetics Wholesale;Cosmetics Retail;General merchandise sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Drug Wholesale;Drug retail;Class III medical device business;food sales;pharmaceutical production;Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Hubei China Tobacco Industry Co. is a private company headquartered in Guangshui, China, that manufactures cigarettes.

ICCAS was founded in 1956. ICCAS is a multi-disciplinary research institute dedicated to the basic research in broad fields of chemical sciences, and to the key developments of the innovative high technologies aiming to the imperative national needs and important strategic targets, as well as to the collaborative high-technology applications and transfers. ICCAS is one of China’s leading chemistry research institutions with high international reputation.

Shanghai Institutes for Biological Sciences CAS is a private company headquartered in Shanghai, China, that operates as researching agency.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

ColBar LifeScience Ltd. develops, manufactures, and commercializes bio-surgical products.

Shanghai Yibien Gene Technology Co., Ltd., established on 2015-11-02, The scope of business includes engaging in genetic technology,Biological Technology,Technology development in the field of medical science and technology,technical consulting,Technical Services,technology transfer(remove human stem cells,Development and application of genetic diagnosis and treatment technology),Instrumentation,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Laboratory equipment and consumables,Sales of computer software, hardware and auxiliary equipment,Medical device management,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Jiangsu Target Biomedical Research Institute Co., Ltd., established on 2008-10-28, Business scope includes biotechnology research and development;Technology transfer for R&D products,technical consulting,Technical Services;Instrumentation,equipment,electronic product,Biochemical reagents,Sales of computer accessories and software;Self-operated and agent import and export business of various commodities and technologies,Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export;food business(limit<food business license>Approved scope);food production(limit<food production license>Approved scope);Cosmetic sales;Cosmetic production(limit<Cosmetic Production License>Approved scope).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Shanghai Yudao Biotechnology Co., Ltd. is a Chinese company located in Shanghai that operates as a biotechnology company. It was founded in 2013.

Versitech Ltd. is a Hong Kong Chinese company located in Hong Kong and ultimately controlled by the Government of Hong Kong Special Administrative Region. The firm provides business services.

Zhanjiang Guoxing Aquatic Technology Co., Ltd., established on 2014-11-19, Business scope includes aquaculture and hatchery;Seedling production,Sales;feed,Shrimp Medicine Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hangzhou Jiahua Hesheng Pharmaceutical Technology Co., Ltd, established on 2022-03-16, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Graphic design and production;Advertising Design,acting;advertising;Organize cultural and artistic exchange activities;Conference and Exhibition Services;Science popularization service;Natural science research and experimental development;Professional Design Services;Production of protective equipment for medical personnel(Ι class medical device);Sales of Class I Medical Devices;Class I Medical Device Leasing;Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Biochemical product technology research and development;Machinery sales;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Mechanical equipment research and development;Corporate Image Planning;Socioeconomic Advisory Services;Information Consulting Service(Not including licensing information consulting services);Consulting and planning service;translation service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Aesku.Diagnostics GmbH & Co. KG is a private company headquartered in Wendelsheim, Germany, with subsidiaries in that country, specializing in surgical and medical instruments and apparatus. Torsten Matthias is the current CEO of the firm.\nThe company says this about itself: AESKU.GROUP, based in Wendelsheim, Germany, is a research-focused supplier of innovative and efficient products and services for the early detection, diagnosis and prognosis of autoimmune diseases. In only ten years since its foundation AESKU.DIAGNOSTICS has become a recognized name in the field of autoimmunity for launching over 150 different products together with uninterrupted services in more than 90 countries worldwide. Simplifying the lab routine with accurate, robust and reliable tests, laying equal emphasis on all major disease sectors, the company has earned a solid reputation in autoimmune diagnostics. Nowadays the AESKU.GROUP is a group of companies that includes AESKU.DIAGNOSTICS (Autoimmunity IVD), AESKU.THERAPY (Autoimmune Therapies), AESKU.SYSTEMS (Lab Automation), AESKU.KIPP INSTITUTE (International Research Cooperation) and the subsidiaries AESKU.INC (US). Besides its own outstanding commitment to research and development AESKU.DIAGNOSTICS has initiated and supports the AESKU.KIPP INSTITUTE, a non-profit organization, primarily active in basic research and interdiciplinary knowledge transfer in autoimmunity.